These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29352597)

  • 21. Genetic and mass spectrometric tools for elucidating the physiological function(s) of cytochrome P450 enzymes from Mycobacterium tuberculosis.
    Ouellet H; Chow ED; Guan S; Cox JS; Burlingame AL; de Montellano PR
    Methods Mol Biol; 2013; 987():79-94. PubMed ID: 23475669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis.
    Mowat CG; Leys D; McLean KJ; Rivers SL; Richmond A; Munro AW; Ortiz Lombardia M; Alzari PM; Reid GA; Chapman SK; Walkinshaw MD
    Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):704-5. PubMed ID: 11914502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A highly conserved mycobacterial cholesterol catabolic pathway.
    García-Fernández E; Frank DJ; Galán B; Kells PM; Podust LM; García JL; Ortiz de Montellano PR
    Environ Microbiol; 2013 Aug; 15(8):2342-59. PubMed ID: 23489718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Structures of the Steroid Binding CYP142 Cytochrome P450 Enzymes from
    Ghith A; Doherty DZ; Bruning JB; Russell RA; De Voss JJ; Bell SG
    ACS Infect Dis; 2022 Aug; 8(8):1606-1617. PubMed ID: 35881654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
    McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
    J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
    Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
    ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
    Driscoll MD; McLean KJ; Levy C; Mast N; Pikuleva IA; Lafite P; Rigby SE; Leys D; Munro AW
    J Biol Chem; 2010 Dec; 285(49):38270-82. PubMed ID: 20889498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How do azoles inhibit cytochrome P450 enzymes? A density functional study.
    Balding PR; Porro CS; McLean KJ; Sutcliffe MJ; Maréchal JD; Munro AW; de Visser SP
    J Phys Chem A; 2008 Dec; 112(50):12911-8. PubMed ID: 18563875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
    Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
    J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121.
    Hudson SA; McLean KJ; Surade S; Yang YQ; Leys D; Ciulli A; Munro AW; Abell C
    Angew Chem Int Ed Engl; 2012 Sep; 51(37):9311-6. PubMed ID: 22890978
    [No Abstract]   [Full Text] [Related]  

  • 31. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis.
    Jackson CJ; Lamb DC; Kelly DE; Kelly SL
    FEMS Microbiol Lett; 2000 Nov; 192(2):159-62. PubMed ID: 11064188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis.
    Davis HJ; Kavanagh ME; Balan T; Abell C; Coyne AG
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3735-40. PubMed ID: 27287372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
    Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
    Ouellet H; Podust LM; de Montellano PR
    J Biol Chem; 2008 Feb; 283(8):5069-80. PubMed ID: 18089574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
    Saxena S; Samala G; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 Apr; 23(7):1402-12. PubMed ID: 25766629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An enlarged, adaptable active site in CYP164 family P450 enzymes, the sole P450 in Mycobacterium leprae.
    Agnew CR; Warrilow AG; Burton NM; Lamb DC; Kelly SL; Brady RL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):391-402. PubMed ID: 22037849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
    Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
    Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I.
    Ekins S; Godbole AA; Kéri G; Orfi L; Pato J; Bhat RS; Verma R; Bradley EK; Nagaraja V
    Tuberculosis (Edinb); 2017 Mar; 103():52-60. PubMed ID: 28237034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.